ImmuCell Corporation Proceeds from Lines of Credit
ImmuCell Corporation (ICCC) reported Proceeds from Lines of Credit of $2.00 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2025-03-28
- ImmuCell Corporation proceeds from lines of credit for the quarter ending 2023-12-31 was $0.00.
- ImmuCell Corporation proceeds from lines of credit for the quarter ending 2023-09-30 was $1.00M.
- ImmuCell Corporation proceeds from lines of credit for the quarter ending 2023-06-30 was $0.00.
- ImmuCell Corporation proceeds from lines of credit for the quarter ending 2023-03-31 was $1.00M.
- ImmuCell Corporation proceeds from lines of credit for fiscal 2023 was $2.00M.
- ImmuCell Corporation proceeds from lines of credit for fiscal 2018 was $500.00K.
| Period end | Proceeds from Lines of Credit 3 month | Proceeds from Lines of Credit 6 month | Proceeds from Lines of Credit 9 month | Proceeds from Lines of Credit 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $1.00M derived: sum of 2 quarters · filed 2025-03-28 | $1.00M derived: sum of 3 quarters · filed 2025-03-28 | $2.00M 10-K · filed 2025-03-28 |
| 2023-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $1.00M derived: sum of 2 quarters · filed 2024-11-13 | $2.00M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $1.00M 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | $1.00M 10-Q · filed 2024-05-14 | |||
| 2018-12-31 | $500.00K 10-K · filed 2020-03-27 | |||
| 2017-06-30 | $500.00K 10-Q · filed 2018-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |